Eli Lilly’s newly approved GLP-1 weight-loss pill, Foundayo, is now available through Amazon-linked channels, including One Medical kiosks and same-day delivery from Amazon Pharmacy. Prescriptions are written through LillyDirect and fulfilled by Amazon Pharmacy after a patient consult with a clinician, and in some cases can be delivered the same day.
Because Foundayo is an oral pill that is stable at room temperature—unlike refrigerated injectable GLP-1 therapies—Amazon can stock it in automated kiosks located at One Medical sites. Amazon Pharmacy executives note that the pill’s lack of cold-chain needs makes kiosk dispensing practical; Amazon kiosks have also been dispensing Novo Nordisk’s oral Wegovy since January.
Amazon introduced the One Medical-linked kiosks in 2025 and currently operates five machines in California. The kiosks are intended to lower access barriers and reduce delivery fees. One Medical serves as Amazon’s primary and urgent care offering; an annual membership is $199, or $99 for Prime members. People without a One Medical membership can still book appointments and use the kiosks. Amazon plans to expand the kiosk program beyond California in 2026 and is talking with outside health systems to place more units.
Patients can also obtain Foundayo through Lilly’s prescribing partners, such as WW International, and some users may qualify for same-day delivery directly through Amazon. Amazon says it aims to expand same-day delivery to roughly 4,500 locations by year’s end. WW and GoodRx have announced self-pay pricing starting at about $149 per month for the lowest dose.
Out-of-pocket costs depend on insurance: some commercially insured patients could pay as little as $25 per month, and Medicare Part D beneficiaries may be able to obtain Foundayo for about $50 per month beginning in July. Lilly provides resources to help patients navigate coverage and savings options.
Clinicians welcome another treatment option for obesity. Experts note that some patients prefer weekly injections while others favor a daily pill; the oral formulation’s lack of refrigeration also makes it more convenient for travel. Foundayo’s dosing typically begins at 0.8 mg, increases to 2.5 mg after 30 days and to 5.5 mg after another 30 days, with potential further increases to 9 mg, 14.5 mg or 17.2 mg at intervals of at least 30 days based on response and tolerance.
If you think you may qualify for Foundayo or another GLP-1 medication, talk with your healthcare provider about eligibility, appropriate dosing and coverage options.